RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 122 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,444 | +2347.5% | 94,257 | +104.4% | 0.00% | – |
| Q2 2023 | $59 | -3.3% | 46,114 | 0.0% | 0.00% | – |
| Q1 2023 | $61 | -11.6% | 46,114 | 0.0% | 0.00% | – |
| Q4 2022 | $69 | -99.9% | 46,114 | 0.0% | 0.00% | – |
| Q3 2022 | $54,000 | +3.8% | 46,114 | 0.0% | 0.00% | – |
| Q2 2022 | $52,000 | -62.3% | 46,114 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $138,000 | +13.1% | 46,114 | 0.0% | 0.00% | – |
| Q4 2021 | $122,000 | -26.9% | 46,114 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $167,000 | -16.5% | 46,114 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $200,000 | +26.6% | 46,114 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $158,000 | -1.9% | 46,114 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $161,000 | +45.0% | 46,114 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $111,000 | +32.1% | 46,114 | 0.0% | 0.00% | – |
| Q2 2020 | $84,000 | +16.7% | 46,114 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $72,000 | -12.2% | 46,114 | +21.0% | 0.00% | – |
| Q4 2019 | $82,000 | +15.5% | 38,100 | 0.0% | 0.00% | – |
| Q3 2019 | $71,000 | -28.3% | 38,100 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $99,000 | +1.0% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $98,000 | +11.4% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $88,000 | -27.9% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $122,000 | +13.0% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $108,000 | -20.0% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $135,000 | -8.8% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $148,000 | +52.6% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $97,000 | -6.7% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $104,000 | -17.5% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $126,000 | +38.5% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $91,000 | -35.0% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $140,000 | +64.7% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $85,000 | +7.6% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $79,000 | -31.3% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $115,000 | +22.3% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $94,000 | -23.0% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $122,000 | -10.3% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $136,000 | +58.1% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $86,000 | +16.2% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $74,000 | -46.4% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $138,000 | -6.8% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $148,000 | +35.8% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $109,000 | -19.9% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $136,000 | +7.1% | 38,100 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $127,000 | – | 38,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |